Clinical and immunologic predictors of death after an acute opportunistic infection: results from ACTG A5164. - Wikidata - awgldk - TriplyDB

Clinical and immunologic predictors of death after an acute opportunistic infection: results from ACTG A5164.

Clinical and immunologic predictors of death after an acute opportunistic infection: results from ACTG A5164.

http://www.wikidata.org/entity/Q34202331

about

Country of residence is associated with distinct inflammatory biomarker signatures in HIV-infected patients.Full blood count values as a predictor of poor outcome of pneumonia among HIV-infected patients.A Low Frequency of IL-17-Producing CD8 T-Cells Is Associated With Persistent Immune Activation in People Living With HIV Despite HAART-Induced Viral Suppression

P2860

Q42318292-A899B406-981B-48F2-897B-E75BB2E019B6 Q52577413-7A36D9C3-9600-4D05-ABBB-663F3BCAECF4 Q58699124-EC025841-E894-4686-8ED1-0273C49B7D62

P2860

Clinical and immunologic predictors of death after an acute opportunistic infection: results from ACTG A5164.

http://www.wikidata.org/entity/Q34202331

description

2014 nî lūn-bûn

@nan

2014 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Clinical and immunologic predi ...... tion: results from ACTG A5164.

@ast

Clinical and immunologic predi ...... tion: results from ACTG A5164.

@en

Clinical and immunologic predi ...... tion: results from ACTG A5164.

@nl

type

label

Clinical and immunologic predi ...... tion: results from ACTG A5164.

@ast

Clinical and immunologic predi ...... tion: results from ACTG A5164.

@en

Clinical and immunologic predi ...... tion: results from ACTG A5164.

@nl

prefLabel

Clinical and immunologic predi ...... tion: results from ACTG A5164.

@ast

Clinical and immunologic predi ...... tion: results from ACTG A5164.

@en

Clinical and immunologic predi ...... tion: results from ACTG A5164.

@nl

P1433

Q34202331-85177BA4-07DD-43B3-8E88-F46E4714F808

P1476

Q34202331-0341D76D-ACEE-4A04-80AA-34689149C452

P2093

Q34202331-1A3577EC-8B05-4E19-91ED-6F15FD598C2D

Q34202331-235A4D6D-D181-48D4-98C9-BAA5D58EAC75

Q34202331-9418F49A-1722-42F9-8862-8C5BE99A0E65

Q34202331-98A0FC8E-A24B-4363-B130-58849F63A122

Q34202331-B23B9364-AF6D-4CEF-A903-F26ACE60EF0B

Q34202331-DE9FA546-C0D3-4A68-A54A-66ABA194F8AD

Q34202331-F89CDF16-7313-4ACA-A086-B24BB2AE53CE

P2860

Q34202331-268FDAEB-4C85-40AA-AE6B-B6BF10B166A0

Q34202331-36FFF5F3-C7F0-4EA3-BD64-28F48CCF29DE

Q34202331-37D43C8E-C5C9-4986-8637-7218F50F7A62

Q34202331-3F8B4545-F751-4C04-854E-15DDC994E58D

Q34202331-550BC0D1-CD5E-4F53-A4BB-E6831BE04EDF

Q34202331-59075EE4-499F-4D94-A74D-FA5CE2B8A202

Q34202331-599668ED-2EC2-4322-AA75-1D7B59D70663

Q34202331-6A0FBCCD-B824-4B7A-B622-D7395F1BFB85

Q34202331-6CD520A0-290A-447D-A3A9-1241C350E1E3

Q34202331-710DAC07-7123-4ED9-ABE3-5FE9DA40607C

P304

Q34202331-991FB359-101E-4BAE-9094-F65D11ABCEB7

P31

Q34202331-CBF2792C-5AA4-43D4-B144-7513D6D3CB7B

P356

Q34202331-76136A0F-2296-4D16-8F17-01FE051A0B29

P433

Q34202331-00594D41-0C41-4228-8D84-B98A3D401F8B

P478

Q34202331-5294CF93-9FBE-42A4-967A-6F8C8F45FFFE

P577

Q34202331-10286EF3-B994-4830-8715-828053911D5D

P698

Q34202331-7B6689B3-CFDF-4CCD-9980-8B544B9CBACA

P932

Q34202331-E23DDD9F-9E4D-4703-B21A-49A78036EBF8

P356

P1433

HIV Clinical Trials

P1476

Clinical and immunologic predi ...... tion: results from ACTG A5164.

@en

P2093

Alejandro Sanchez

http://www.w3.org/2001/XMLSchema#string

Andrew R Zolopa

http://www.w3.org/2001/XMLSchema#string

David M Asmuth

http://www.w3.org/2001/XMLSchema#string

Fred R Sattler

http://www.w3.org/2001/XMLSchema#string

Lauren Komarow

http://www.w3.org/2001/XMLSchema#string

Philip M Grant

http://www.w3.org/2001/XMLSchema#string

Richard B Pollard

http://www.w3.org/2001/XMLSchema#string

P2860

Clinical features and serum biomarkers in HIV immune reconstitution inflammatory syndrome after cryptococcal meningitis: a prospective cohort study

Microbial translocation is a cause of systemic immune activation in chronic HIV infection

Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells

Inflammatory and coagulation biomarkers and mortality in patients with HIV infection

Risk factors and outcomes for late presentation for HIV-positive persons in Europe: results from the Collaboration of Observational HIV Epidemiological Research Europe Study (COHERE)

HIV care and treatment factors associated with improved survival during TB treatment in Thailand: an observational study

Pretreatment levels of soluble cellular receptors and interleukin-6 are associated with HIV disease progression in subjects treated with highly active antiretroviral therapy.

Benefit of antiretroviral therapy on survival of human immunodeficiency virus-infected patients admitted to an intensive care unit

Plasma levels of soluble CD14 independently predict mortality in HIV infection.

Higher levels of CRP, D-dimer, IL-6, and hyaluronic acid before initiation of antiretroviral therapy (ART) are associated with increased risk of AIDS or death

P304

133-139

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1310/HCT1504-133

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

15

http://www.w3.org/2001/XMLSchema#string

P577

2014-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25143022

http://www.w3.org/2001/XMLSchema#string

P932

4167015

http://www.w3.org/2001/XMLSchema#string